This article explores the potential long-term effects of GLP-1 medications in treating obesity, their benefits, and considerations for individuals using these therapies
Depression involves mood changes and emotional withdrawal
Your provider will develop a customized tirzepatide treatment plan, making healthcare accessible and comfortable
Semaglutide (Ozempic, Wegovy) is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist
No supply interruptions occur during flu season
The Role of Medication Adherence in Preventing Rebound Weight Gain Consistent, uninterrupted dosing is essential for maintaining semaglutide's appetite-suppressing benefits